Cardiovascular Systems, Inc. Reports Fiscal 2022 Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cardiovascular Systems (CSII) PT Lowered to $34 at Oppenheimer
February 3, 2022 12:54 PM ESTOppenheimer analyst Suraj Kalia lowered the price target on Cardiovascular Systems (NASDAQ: CSII) to $34.00 (from $40.00) while maintaining an Outperform rating following results.
... MoreCardiovascular Systems (CSII) Misses Q2 EPS by 10c
February 3, 2022 6:13 AM ESTCardiovascular Systems (NASDAQ: CSII) reported Q2 EPS of ($0.23), $0.10 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $59.13 million versus the consensus estimate of $63.17 million.
GUIDANCE:
Cardiovascular Systems sees FY2022 revenue of $235-245 million.
For earnings history and earnings-related data on Cardiovascular Systems (CSII) click here.
... More